首页> 外国专利> Agent for prevention and treatment of osteoporosis and its uses

Agent for prevention and treatment of osteoporosis and its uses

机译:骨质疏松症防治剂及其用途

摘要

A mineral-vitamin complex for osteoporosis includes at least 92 mass % of the mineral-vitamin complex of amino acids and Krebs cycle acids and/or Krebs cycle acid salts, wherein the amino acids include glycine of between 1% and 80% of the mineral-vitamin complex, and wherein the Krebs cycle acids and/or Krebs cycle acid salts are up to 5 mass % of the mineral-vitamin complex; and valine, leucine and isoleucine such that a mass ratio of glycine to a sum of valine+leucine+isoleucine is in a range of 10-1000. Optionally, the valine, leucine and isoleucine are derived from dry milk, any stable dry product derived from milk and/or a mix thereof. Optionally, the following compounds are used as a source of Krebs cycle acid salts: Y-Me-Y.nH2O, where Me—divalent metal, from Ca, Mg, Zn group, Y—anion of an acid participating in Krebs cycle, and n=0-12.
机译:用于骨质疏松症的矿物质-维生素复合物包括氨基酸和克雷布斯循环酸和/或克雷布斯循环酸盐的矿物质-维生素复合物的至少92质量%,其中氨基酸包括占矿物质的1%至80%的甘氨酸-维生素复合物,其中所述克雷布斯循环酸和/或克雷布斯循环酸盐占矿物-维生素复合物的至多5质量%;缬氨酸,亮氨酸和异亮氨酸,使得甘氨酸与缬氨酸+亮氨酸+异亮氨酸之和的质量比在10-1000的范围内。任选地,缬氨酸,亮氨酸和异亮氨酸衍生自干乳,任何稳定的干燥产品均源于乳和/或其混合物。可选地,以下化合物用作Krebs循环酸盐的来源:Y-Me-Y.nH 2 O,其中Me-二价金属,来自Ca,Mg,Zn基,Y-阴离子酸参与克雷布斯循环,n = 0-12。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号